2010
DOI: 10.1016/j.amjcard.2010.01.353
|View full text |Cite
|
Sign up to set email alerts
|

Comparison of Long-Term (4-Year) Outcomes of Patients With Unprotected Left Main Coronary Artery Narrowing Treated With Drug-Eluting Stents Versus Coronary-Artery Bypass Grafting

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
29
1
3

Year Published

2011
2011
2018
2018

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 37 publications
(33 citation statements)
references
References 27 publications
0
29
1
3
Order By: Relevance
“…Untreated OSA was mostly associated with non-TLR. Although the number of the diseased vessels has been reported as a predictor of non-TLR, 36,37 in the present study, there was no signifi cant diff erence in the number of the diseased vessels among the groups. However, two-thirds of non-TLR in the CPAP 2 /AHI Ն 15 group was a result of a baseline stenosis , 50% by angiography.…”
Section: Discussioncontrasting
confidence: 49%
“…Untreated OSA was mostly associated with non-TLR. Although the number of the diseased vessels has been reported as a predictor of non-TLR, 36,37 in the present study, there was no signifi cant diff erence in the number of the diseased vessels among the groups. However, two-thirds of non-TLR in the CPAP 2 /AHI Ն 15 group was a result of a baseline stenosis , 50% by angiography.…”
Section: Discussioncontrasting
confidence: 49%
“…After critical appraisal, fifteen studies with 5,479 patients were included in this meta-analysis. Thirteen studies [7,8,9,10,11,12,14,17,18,19,20,21,22] were observational study and two studies were randomized controlled trials [13,15]. The main characteristics of the included studies were summarized in table 1.…”
Section: Resultsmentioning
confidence: 99%
“…Six studies with 1,830 patients investigated the early outcomes (<30 days) after treatment with DES or CABG [9,10,17,19,21,22]. Pooled effects showed no significant difference in the incidence of death (OR: 0.70, 95% CI: 0.20–2.47, p = 0.58), MI (OR: 1.42, 95% CI: 0.32–6.26, p = 0.64), cerebrovascular events (OR: 0.50, 95% CI: 0.12–2.13), and composite endpoint (OR: 0.69, 95% CI: 0.30–1.59, p = 0.38) between the DES group and the CABG group during the initial 30 days (fig.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Эффективность и безопасность ЧКВ в сравнении с КШ у пациентов с поражением ствола ЛКА изучались в нескольких нерандомизированных исследованиях и регистрах [6-8, [49][50][51]. Было показано, что выполне-ние ЧКВ у этой категории пациентов является оправдан-ным, а результаты в большинстве случаев сопоставимы с КШ.…”
Section: чкв в сравнении с кш у пациентов с поражением ствола лкаunclassified